Peter A. Riedell - Publications, H-index & Citations

Back

Peter A. Riedell

indiana university system

31H-index

288Paper Count

5.8KCitation Count

Published Papers 55

Publication Date

Outcomes and safety of CAR-T cell therapy in B-NHL patients with reduced left ventricular ejection fraction

Transplantation and Cellular Therapy

IF4.4

2026-05-29

PREAI

Alexandra E. Rojek; Jia Guo; Justin Kline; Satyajit Kosuri; Michael R. Bishop; Jeanne DeCara; Peter A. Riedell

Save

Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes

Signal Transduction and Targeted Therapy

IF52.7

2026-04-27

OAAI

Nada S. Aboelella; Ryan Park; Erting Tang; Nicholas Asby; Joshua D. Ho; Tony Pan; Sidney Wang; Lishi Xie; Justin P. Kline; Peter A. Riedell; Jun Huang; James L. LaBelle

Save

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study

Blood Cancer Journal

IF11.6

2026-03-23

OAAI

Matthew Hamby; Brian L. Egleston; Zachary A. K. Frosch; Raphael E. Steiner; Ariela Noy; Veronica Carvajal; Emeline R. Chong; Seda S. Tolu; Gaston Jean-Louis; Jennifer E. Amengual; Romil Patel; Sairah Ahmed; John Sharp; Timothy Voorhees; Robert Baiocchi; Andres Ramirez-Gamero; Jorge J. Castillo; Emily Hamburger; Christopher Dittus; Imran A. Nizamuddin; Neha Mehta-Shah; Nyein Nyein Thaw Dar; Jose Sandoval-Sus; Alexandra E. Rojek; Peter A. Riedell; Niloufer Khan; Alexey Danilov; Vinod Solipuram; Paul G. Rubinstein; Anthony Ariotti; Gita Suneja; Alexander Vartanov; Charles Milrod; Adam J. Olszewski; Gordon Smilnak; Emily Ayers; Sahaj Desai; Joanna M. Rhodes; Gabriella Magarelli; Tatyana Feldman; Meredith Pellon; David M. Aboulafia; William Bae; Carlos Galvez; Vineel Bhatlapenumarthi; Mehdi Hamadani; Stefan K. Barta

Save

Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 2.2026 Featured Updates to the NCCN Guidelines

Journal of the National Comprehensive Cancer Network

IF16.4

2026-03-01

PREAI

Wierda, William G.; Brown, Jennifer; Abramson, Jeremy S.; Awan, Farrukh; Bociek, Greg; Boyer, Daniel; Cortese, Matthew; Cripe, Larry; D'Angelo, Christopher; Darnell, Elijah; Davis, Randall S.; Eradat, Herbert; Esteghamat, Naseem; Fitzgerald, Lindsey; Fletcher, Christopher D.; Gaballa, Sameh; Huntington, Scott; Kahl, Brad; Kamdar, Manali; Kipps, Thomas J.; Ma, Shuo; Mosse, Claudio A.; Nakhoda, Shazia; Parikh, Sameer A.; Riedell, Peter; Schorr, Andrew; Schuster, Stephen; Seshadri, Madhav; Shanafelt, Tait; Siddiqi, Tanya; Sitlinger, Andrea; Thompson, Meghan; Ujjani, Chaitra; Wagner-Johnston, Nina; Woyach, Jennifer A.; Dwyer, Mary; Sundar, Hema

Save

New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma

Blood Advances

IF7.1

2025-08-18

OAAI

Uri Greenbaum; Hamza Hashmi; Mahmoud Elsawy; Soyoung Kim; Amy Moskop; Temitope Oloyede; Farrukh T Awan; Veronika Bachanova; Talha Badar; Merav Bar; Pere Barba; Amer M Beitinjaneh; Amanda Cashen; Bhagirathbhai Dholaria; Umar Farooq; Jessica Foglesong; Siddhartha Ganguly; Peiman Hematti; LaQuisa C Hill; Michael D Jain; Tania Jain; Partow Kabriaei; Adam S Kittai; Frederick L Locke; Premal D Lulla; Joseph P McGuirk; Elena Mead; Alberto Mussetti; Taiga Nishihori; Amanda L Olson; Martina Pennisi; Miguel-Angel Perales; Praveen Ramakrishnan Geethakumari; Peter A Riedell; Wael Saber; Roni Shouval; Elizabeth J Shpall; Margarida Magalhaes-Silverman; Christopher Strouse; Cameron J Turtle; Anusha Vallurupalli; Kitsada Wudhikarn; Marcelo C Pasquini; Sairah Ahmed; Mohamed Sorror

Save

Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis

Transplantation and Cellular Therapy

IF4.4

2025-08-05

PREAI

Kalyan V. Nadiminti; Kwang W. Ahn; Jinalben Patel; Qinghua Lian; Evandro Bezerra; Andy Chen; Siddhartha Ganguly; Usama Gergis; Hamza Hashmi; Mohamed A. Kharfan-Dabaja; John Kuruvilla; Lazaros Lekakis; Frederick L. Locke; Hemant Murthy; Muhamad Alhaj Mousthafa; Miguel-Angel Perales; Priyanka Pophali; Peter A. Riedell; Nirav N. Shah; Trent Wang

Save

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL

Blood Advances

IF7.1

2025-07-29

OAAI

Kirk Cahill; James Godfrey; Chadi Nabhan; Justin Kline; Peter A. Riedell; Kenneth S. Cohen; Sunil Narula; Theodore G. Karrison; Jessica Robertson; Reem Karmali; Parameswaran Venugopal; Seo-Hyun Kim; Aaron P. Rapoport; Seung Tae Lee; Jennie Law; Paul A. S. Fishkin; Iris Isufi; Mario Velasco; Lynne Kaminer; Sonali M. Smith

Save

Two-stage CD8+ CAR T-cell differentiation in patients with large B-cell lymphoma

NATURE COMMUNICATIONS

IF15.7

2025-05-06

OAAI

Cao, Guoshuai; Hu, Yifei; Pan, Tony; Tang, Erting; Asby, Nicholas; Althaus, Thomas; Wan, Jun; Riedell, Peter A.; Bishop, Michael R.; Kline, Justin P.

Save

Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study

Blood Advances

IF7.1

2025-05-05

OAAI

Alison Sehgal; Daanish Hoda; Peter A. Riedell; Nilanjan Ghosh; Mehdi Hamadani; Gerhard C. Hildebrandt; John E. Godwin; Patrick M. Reagan; Nina D. Wagner-Johnston; James Essell; Rajneesh Nath; Scott R. Solomon; Rebecca Champion; Edward Licitra; Suzanne Fanning; Neel K. Gupta; Victor A. Chow; Brenda Yuan; Zhi Yang; Ken Ogasawara; Jerill Thorpe; Leo I. Gordon

Save

Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis

BLOOD CANCER JOURNAL

IF11.6

2025-04-15

OAAI

Sawalha, Y.; Sarosiek, S.; Welkie, R. L.; Seif, S.; Thapa, S.; Zanwar, S.; Cahill, K.; Treitman, R.; Shah, H.; Arora, S.; Pongas, G.; Winter, A.; Major, A.; Riedell, P. A.; Palomba, M. L.; Kapoor, P.; Grajales-Cruz, A.; Shain, K. H.; Thomas, S. K.; Castillo, J. J.

Save

Leveraging the Immunomodulatory Potential of Ibrutinib for Improved Outcomes of T Cell-Mediated Therapies of B Cell Malignancies: A Narrative Review

TARGETED ONCOLOGY

IF4

2025-03-01

OAAI

Miklos, David B.; Riedell, Peter A.; Bokun, Alex; Chavez, Julio C.; Schuster, Stephen J.

Save

Treatment Patterns and Outcomes Following Progression of Disease Post-CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter Analysis

BLOOD

IF23.1

2024-11-05

PREAI

Epstein-Peterson, Zachary D.; Lionel, Anath C.; Joseph, Ashlee; Drill, Esther; Atallah-Yunes, Suheil Albert; Brooks, Taylor R.; Chong, Elise A.; Chong, Emeline R.; Dela Cruz, Jamie; Frank, Matthew J.; Ip, Andrew; Iqbal, Madiha; Jacobson, Caron A.; Kamdar, Manali K.; Karmali, Reem; Maddocks, Kami J.; Matasar, Matthew; Merryman, Reid W.; Munoz, Javier; Riedell, Peter A.; Ryan, Christine E.; Salles, Gilles; Sauter, Craig S.; Sawalha, Yazeed; Shouval, Roni; Shukla, Navika; Stanisic, Alexander, V; Therwhanger, Dylan; Van Besien, Herman; Wang, Yucai; Yamshon, Samuel; Zelenetz, Andrew D.; Palomba, Maria Lia; Jain, Preetesh; Kumar, Anita

Save

Preliminary Efficacy and Safety of a Phase 1/2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab in Patients with Relapsed/Refractory and Previously Untreated Mantle Cell Lymphoma (MAVO)

BLOOD

IF23.1

2024-11-05

PREAI

Kim, Austin I.; Armand, Philippe; Ryan, Christine E.; Redd, Robert A.; Forsyth, Megan; Mai, Juniper; Pazienza, Samantha; Bresnahan, Caitlin; Kats, Vanessa M.; Abdulkarim, Salah; Waisgerber, Susan M.; Merryman, Reid W.; Fisher, David C.; Ahn, Inhye E.; Crombie, Jennifer L.; Odejide, Oreofe O.; Lacasce, Ann S.; Jacobson, Caron A.; Jacobsen, Eric D.; Parry, Erin M.; Qualls, David A.; Bessnow, Amy C.; Davids, Matthew S.; Brown, Jennifer R.; Arnason, Jon E.; Leukam, Michael; Riedell, Peter A.; Murakami, Mark A.

Save

Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Updated Follow-up of Transcend CLL 004

BLOOD

IF23.1

2024-11-05

PREAI

Siddiqi, Tanya; Gauthier, Jordan; Kenderian, Saad S.; Brander, Danielle M.; Dorritie, Kathleen; Soumerai, Jacob D.; Reidell, Peter A.; Shah, Nirav N.; Nath, Rajneesh; Andreadis, Charalambos; Ermann, Daniel A.; Ma, Shuo; Feldman, Tatyana; Solomon, Scott R.; Schuster, Stephen J.; Tuazon, Sherilyn A.; Perna, Serena K.; Ou, San-San; Rane, Neha; Papp, Eniko; Chen, Yizhe; Wierda, William G.

Save

Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel

BLOOD ADVANCES

IF7.1

2024-10-11

OAAI

Ahmed, Nausheen; Wesson, William; Lut, Forat; Porter, David L.; Bachanova, Veronika; Nastoupil, Loretta J.; Perales, Miguel-Angel; Maziarz, Richard T.; Brower, Jamie; Shah, Gunjan L.; Chen, Andy I.; Oluwole, Olalekan O.; Schuster, Stephen J.; Bishop, Michael R.; McGuirk, Joseph P.; Riedell, Peter A.

Save

Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review (vol 19, pg 495, 2024)

TARGETED ONCOLOGY

IF4

2024-07-19

OAAI

Fowler, Nathan Hale; Chavez, Julio C.; Riedell, Peter A.

Save

Optimization of older adults by a geriatric assessment-guided multidisciplinary clinic before CAR T-cell therapy

BLOOD ADVANCES

IF7.1

2024-07-12

OAAI

Yates, Samuel J.; Cursio, John F.; Artz, Andrew; Kordas, Keriann; Bishop, Michael R.; Derman, Benjamin A.; Kosuri, Satyajit; Riedell, Peter A.; Kline, Justin; Jakubowiak, Andrzej; Mortel, Mylove; Johnson, Shalitha; Nawas, Mariam T.

Save

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

BLOOD CANCER JOURNAL

IF11.6

2024-07-08

OAAI

Shadman, Mazyar; Ahn, Kwang W.; Kaur, Manmeet; Lekakis, Lazaros; Beitinjaneh, Amer; Iqbal, Madiha; Ahmed, Nausheen; Hill, Brian; Hossain, Nasheed M.; Riedell, Peter; Gopal, Ajay K.; Grover, Natalie; Frigault, Matthew; Brammer, Jonathan; Ghosh, Nilanjan; Merryman, Reid; Lazaryan, Aleksandr; Ram, Ron; Hertzberg, Mark; Savani, Bipin; Awan, Farrukh; Khimani, Farhad; Ahmed, Sairah; Kenkre, Vaishalee P.; Ulrickson, Matthew; Shah, Nirav; Kharfan-Dabaja, Mohamed A.; Herrera, Alex; Sauter, Craig; Hamadani, Mehdi

Save

CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience

BLOOD ADVANCES

IF7.1

2024-06-28

OAAI

Ahmed, Gulrayz; Alsouqi, Aseel; Szabo, Aniko; Samples, Laura; Shadman, Mazyar; Awan, Farrukh T.; Rojek, Alexandra E.; Riedell, Peter A.; Iqbal, Madiha; Fenske, Timothy S.; Kharfan-Dabaja, Mohamed A.; Ito, Sawa; Hamadani, Mehdi

Save

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

BLOOD ADVANCES

IF7.1

2024-06-28

OAAI

Bhansali, Rahul S.; Ellin, Fredrik; Relander, Thomas; Cao, Miao; Li, Wenrui; Long, Qi; Ganesan, Nivetha; Stuver, Robert; Horwitz, Steven M.; Wudhikarn, Kitsada; Hwang, Steven R.; Bennani, N. Nora; Chavez, Julio; Sokol, Lubomir; Saeed, Hayder; Duan, Frank; Porcu, Pierluigi; Pullarkat, Priyanka; Mehta-Shah, Neha; Zain, Jasmine M.; Ruiz, Miguel; Brammer, Jonathan E.; Prakash, Rishab; Iyer, Swaminathan P.; Olszewski, Adam J.; Major, Ajay; Riedell, Peter A.; Smith, Sonali M.; Goldin, Caroline; Haverkos, Bradley; Hu, Bei; Zhuang, Tony Z.; Allen, Pamela B.; Toama, Wael; Janakiram, Murali; Brooks, Taylor R.; Jagadeesh, Deepa; Hariharan, Nisha; Goodman, Aaron M.; Hartman, Gabrielle; Ghione, Paola; Fayyaz, Fatima; Rhodes, Joanna M.; Chong, Elise A.; Gerson, James N.; Landsburg, Daniel J.; Nasta, Sunita D.; Schuster, Stephen J.; Svoboda, Jakub; Jerkeman, Mats; Barta, Stefan K.

Save

Research Directions